SOPHiA GENETICSSOPH
About: Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.
Employees: 449
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0.55% more ownership
Funds ownership: 26.95% [Q1] → 27.5% (+0.55%) [Q2]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q1] → 1 (+0) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
3% less funds holding
Funds holding: 32 [Q1] → 31 (-1) [Q2]
5% less capital invested
Capital invested by funds: $86.8M [Q1] → $82.3M (-$4.42M) [Q2]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for SOPH.
Financial journalist opinion
Based on 4 articles about SOPH published over the past 30 days
